MacDougall Biomedical Communications Inc. (MBI), European Office

https://www.macbiocom.com

	Start	2014-12-01 existent
	End	2020-09-22 renamed data ca.
	Group	MacDougall Biomedical Communications Inc. (MBI)
	Today	MacDougall Advisors Inc., European Office
	Successor	MacDougall Advisors Inc., European Office
	Industry	public relations / investor relations / marcom (services)
	Person	Schweitzer, Gretchen (Trophic Comunications 201801 before MacDougall European Office)
	Person 2	Brkulj, Mario (MacDougall 201511 VP before MorphoSys + Biocom)

	Region	München (Munich)
	Country	Germany
	Street	5–7 Zweibrückenstr.
	City	80331 München
	Tel	+49-89-2424-3494
		Address record changed: 2020-12-02

Basic data	Employees	B: 11 to 50 (2014-11-01)


		Record changed: 2023-12-30

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for MacDougall Biomedical Communications Inc. (MBI)

[1] Omeicos Therapeutics GmbH. (7/17/18). "Press Release: Omeicos Therapeutics Announces Compelling First-in-Human Data on Lead Compound OMT-28 and Prepares Phase 2 Trial in Atrial Fibrillation". Berlin....
[2] Pieris Pharmaceuticals, Inc.. (10/2/17). "Press Release: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Trial for Fully Proprietary Lead IO Program, PRS-343". Boston, MA....
[3] Immunicum AB. (8/17/17). "Press Release: Immunicum Completes Strategic Analysis and Defines Updated Clinical Development Plan for Ilixadencel"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]